Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Download original image
Table. 1. Drugs in Clinical Trial for Gastroesophageal Reflux Disease Treatment
H2RAs, histamine type 2 receptor antagonist; PPIs, proton pump inhibitors; P-CABs, potassium-competitive acid blockers; TLESR, transient lower esophageal sphincter relaxation; TRPV1, transient receptor potential vanilloid 1.
J Neurogastroenterol Motil 2014;20:6~16
© J Neurogastroenterol Motil